Beauty Farm Medical and Health Industry Inc. (FRA:XC5)

FRA:XC5 Statistics

Total Valuation

FRA:XC5 has a market cap or net worth of EUR 685.86 million. The enterprise value is 544.42 million.

Market Cap	685.86M
Enterprise Value	544.42M

Important Dates

The next estimated earnings date is Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	Aug 19, 2025

Share Statistics

Current Share Class	234.86M
Shares Outstanding	n/a
Shares Change (YoY)	-0.15%
Shares Change (QoQ)	+0.29%
Owned by Insiders (%)	34.16%
Owned by Institutions (%)	2.07%
Float	76.04M

Valuation Ratios

The trailing PE ratio is 21.47 and the forward PE ratio is 14.71.

PE Ratio	21.47
Forward PE	14.71
PS Ratio	1.99
PB Ratio	6.21
P/TBV Ratio	n/a
P/FCF Ratio	6.26
P/OCF Ratio	5.86
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.79, with an EV/FCF ratio of 4.97.

EV / Earnings	17.04
EV / Sales	1.56
EV / EBITDA	5.79
EV / EBIT	12.20
EV / FCF	4.97

Financial Position

The company has a current ratio of 0.84, with a Debt / Equity ratio of 0.84.

Current Ratio	0.84
Quick Ratio	0.75
Debt / Equity	0.84
Debt / EBITDA	1.00
Debt / FCF	0.84
Interest Coverage	12.71

Financial Efficiency

Return on equity (ROE) is 33.02% and return on invested capital (ROIC) is 14.51%.

Return on Equity (ROE)	33.02%
Return on Assets (ROA)	5.98%
Return on Invested Capital (ROIC)	14.51%
Return on Capital Employed (ROCE)	23.86%
Revenue Per Employee	63,891
Profits Per Employee	5,934
Employee Count	5,609
Asset Turnover	0.75
Inventory Turnover	6.80

Taxes

In the past 12 months, FRA:XC5 has paid 9.62 million in taxes.

Income Tax	9.62M
Effective Tax Rate	21.40%

Stock Price Statistics

The stock price has increased by +21.62% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+21.62%
50-Day Moving Average	2.91
200-Day Moving Average	2.69
Relative Strength Index (RSI)	46.89
Average Volume (20 Days)	61

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:XC5 had revenue of EUR 343.93 million and earned 31.94 million in profits. Earnings per share was 0.14.

Revenue	343.93M
Gross Profit	163.50M
Operating Income	43.87M
Pretax Income	44.94M
Net Income	31.94M
EBITDA	62.45M
EBIT	43.87M
Earnings Per Share (EPS)	0.14

Balance Sheet

The company has 237.42 million in cash and 92.60 million in debt, with a net cash position of 144.82 million.

Cash & Cash Equivalents	237.42M
Total Debt	92.60M
Net Cash	144.82M
Net Cash Per Share	n/a
Equity (Book Value)	110.42M
Book Value Per Share	0.44
Working Capital	-51.95M

Cash Flow

In the last 12 months, operating cash flow was 116.99 million and capital expenditures -7.36 million, giving a free cash flow of 109.63 million.

Operating Cash Flow	116.99M
Capital Expenditures	-7.36M
Free Cash Flow	109.63M
FCF Per Share	n/a

Margins

Gross margin is 47.54%, with operating and profit margins of 12.76% and 9.29%.

Gross Margin	47.54%
Operating Margin	12.76%
Pretax Margin	13.07%
Profit Margin	9.29%
EBITDA Margin	18.16%
EBIT Margin	12.76%
FCF Margin	31.88%

Dividends & Yields

This stock pays an annual dividend of 0.06, which amounts to a dividend yield of 2.11%.

Dividend Per Share	0.06
Dividend Yield	2.11%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	3
Payout Ratio	41.35%
Buyback Yield	0.15%
Shareholder Yield	2.26%
Earnings Yield	4.66%
FCF Yield	15.98%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:XC5 has an Altman Z-Score of 1.75 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.75
Piotroski F-Score	7